ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Frederick RFP Available Oct. 22; Three Four May Challenge L-B

August 27, 1976

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million

August 26, 1988

DCPC Advisers Ok Four New Grant Programs To Foster Prevention

May 22, 1992

In Brief: Mary Lasker To Be Named To NIH Director’s Advisory Committee; Amos Appointment Official

July 18, 1980

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978